Veradigm (NASDAQ:MDRX) Shares Gap Up – Should You Buy?

Veradigm Inc. (NASDAQ:MDRXGet Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $4.58, but opened at $5.00. Veradigm shares last traded at $4.65, with a volume of 975 shares traded.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Veradigm to a “hold” rating in a report on Saturday, March 7th.

Get Our Latest Stock Report on Veradigm

Veradigm Trading Down 1.9%

The stock has a market cap of $496.58 million, a price-to-earnings ratio of 23.25 and a beta of 0.54. The firm’s 50 day moving average is $4.57 and its two-hundred day moving average is $4.69.

About Veradigm

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Further Reading

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.